Want to join the conversation?
$HPQ 2Q15 10-Q: In the three months ended April 30, 2015, HP repurchased 18MM shares of common stock at cost of $0.6Bil vs. 27MM shares at cost of $0.8Bil in 2Q14. As of April 30, 2015, HP had remaining authorization of $2.7Bil for future share repurchases under the $10Bil repurchase authorization approved by BoD on July 21, 2011.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.